<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39392878</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-3907</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of proteome research</Title><ISOAbbreviation>J Proteome Res</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Assessment of Nasopharyngeal Biomarkers Post-COVID-19: Unveiling Persistent Markers and Severity Correlations.</ArticleTitle><Pagination><StartPage>5064</StartPage><EndPage>5084</EndPage><MedlinePgn>5064-5084</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jproteome.4c00536</ELocationID><Abstract><AbstractText>SARS-CoV-19 infection provokes a variety of symptoms; most patients present mild/moderate symptoms, whereas a small proportion of patients progress to severe illness with multiorgan failure accompanied by metabolic disturbances requiring ICU-level care. Given the importance of the disease, researchers focused on identifying severity-associated biomarkers in infected patients as well as markers associated with patients suffering long-COVID. However, little is known about the presence of biomarkers that remain a few years after SARS-CoV-2 infection once the patients fully recover of the symptoms. In this study, we evaluated the presence of persistent biomarkers in the nasopharyngeal tract two years after SARS-Cov-2 infection in fully asymptomatic patients, taking into account the severity of their infection (mild/moderate and severe infections). In addition to the direct identification of several components of the Coronavirus Infection Pathway in those individuals that suffered severe infections, we describe herein 371 proteins and their associated canonical pathways that define the different adverse effects of SARS-CoV-2 infections. The persistence of these biomarkers for up to two years after infection, along with their ability to distinguish the severity of the infection endured, highlights the surprising presence of persistent nasopharyngeal exudate changes in fully recovered patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Redondo-Calvo</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, University General Hospital, SESCAM, Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Castilla-La Mancha, Castilla La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabanal-Ruiz</LastName><ForeName>Yoana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Regional Centre for Biomedical Research, Research Institute of Castilla-La Mancha (IDISCAM), University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verdugo-Moreno</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bejarano-Ram&#xed;rez</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Castilla-La Mancha, Castilla La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University General Hospital, Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodoque-Villar</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dur&#xe1;n-Prado</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9652-5765</Identifier><AffiliationInfo><Affiliation>Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Regional Centre for Biomedical Research, Research Institute of Castilla-La Mancha (IDISCAM), University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illescas</LastName><ForeName>Soledad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University General Hospital, Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chicano-Galvez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9481-9628</Identifier><AffiliationInfo><Affiliation>IMIBIC Mass Spectrometry and Molecular Imaging Unit (IMSMI). Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba (UCO), C&#xf3;rdoba 14004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Romero</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Alarc&#xf3;n</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3807-318X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, University General Hospital, Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arias-Pardilla</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Juarez</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padin</LastName><ForeName>Juan Fernando</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-4585-9401</Identifier><AffiliationInfo><Affiliation>Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Regional Centre for Biomedical Research, Research Institute of Castilla-La Mancha (IDISCAM), University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peinado</LastName><ForeName>Juan Ram&#xf3;n</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-0004-7963</Identifier><AffiliationInfo><Affiliation>Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Regional Centre for Biomedical Research, Research Institute of Castilla-La Mancha (IDISCAM), University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, Ciudad Real 13071, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano-Oviedo</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Traslational Investigation Unit, University General Hospital, SESCAM. Research Institute of Castilla-La Mancha (IDISCAM), Ciudad Real 13004, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Proteome Res</MedlineTA><NlmUniqueID>101128775</NlmUniqueID><ISSNLinking>1535-3893</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="Y">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>The
authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39392878</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.4c00536</ArticleId><ArticleId IdType="pmc">PMC11536464</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Narayanan S. A.; Jamison D. A. Jr.; Guarnieri J. W.; Zaksas V.; Topper M.; Koutnik A. P.; Park J.; Clark K. B.; Enguita F. J.; Leit&#xe3;o A. L.; et al. A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection. Eur. J. Hum. Genet. 2024, 32 (1), 10&#x2013;20. 10.1038/s41431-023-01462-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-023-01462-1</ArticleId><ArticleId IdType="pmc">PMC10772081</ArticleId><ArticleId IdType="pubmed">37938797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginestra J. C.; Mitchell O. J. L.; Anesi G. L.; Christie J. D. COVID-19 Critical Illness: A Data-Driven Review. Annu. Rev. Med. 2022, 73, 95&#x2013;111. 10.1146/annurev-med-042420-110629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042420-110629</ArticleId><ArticleId IdType="pmc">PMC8795486</ArticleId><ArticleId IdType="pubmed">34520220</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasif W. A.; El-Moursy Ali A. S.; Hasan Mukhtar M.; Alhuzali A. M. H.; Yahya Alnashri Y. A.; Ahmed G. Z. I.; et al. Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review. Anemia 2022, 2022, 9104209.10.1155/2022/9104209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9104209</ArticleId><ArticleId IdType="pmc">PMC8924600</ArticleId><ArticleId IdType="pubmed">35310133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F.; Huang S.; Gao R.; Zhou Y.; Lai C.; Li Z.; Xian W.; Qian X.; Li Z.; Huang Y.; et al. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discov. 2020, 6 (1), 83.10.1038/s41421-020-00231-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00231-4</ArticleId><ArticleId IdType="pmc">PMC7653987</ArticleId><ArticleId IdType="pubmed">33298875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X.; Yu Y.; Xu J.; Shu H.; Xia J.; Liu H.; Wu Y.; Zhang L.; Yu Z.; Fang M.; et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020, 8 (5), 475&#x2013;481. 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayass M. A.; Cao W.; Zhang J.; Dai J.; Zhu K.; Tripathi T.; Griko N.; Pashkov V.; Abi-Mosleh L. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system. PLoS One 2022, 17 (9), e027422810.1371/journal.pone.0274228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274228</ArticleId><ArticleId IdType="pmc">PMC9467311</ArticleId><ArticleId IdType="pubmed">36094909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi X.; Liu W.; Ding X.; Liang S.; Zheng Y.; Zhu X.; Quan S.; Yi X.; Xiang N.; Du J.; et al. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep. 2022, 38 (3), 110271.10.1016/j.celrep.2021.110271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110271</ArticleId><ArticleId IdType="pmc">PMC8712267</ArticleId><ArticleId IdType="pubmed">35026155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S.; Klaeger S.; Chea V. A.; Carulli I. P.; Rachimi S.; Black K. E.; Filbin M.; Hariri L. P.; Knipe R. S.; Padera R. F.; et al. Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies. Front. Immunol. 2023, 14, 1269335.10.3389/fimmu.2023.1269335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1269335</ArticleId><ArticleId IdType="pmc">PMC10628763</ArticleId><ArticleId IdType="pubmed">37942334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W.; Altay O.; Arif M.; Edfors F.; Doganay L.; Mardinoglu A.; Uhlen M.; Fagerberg L. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms. EBioMedicine 2021, 74, 103723.10.1016/j.ebiom.2021.103723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103723</ArticleId><ArticleId IdType="pmc">PMC8626206</ArticleId><ArticleId IdType="pubmed">34844191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X.; Wang S.; Zhang W.; Li C.; Guo L.; Wang Z.; Li H.; Zhang H.; Zhou Y.; Liang W.; et al. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine 2023, 98, 104851.10.1016/j.ebiom.2023.104851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104851</ArticleId><ArticleId IdType="pmc">PMC10660018</ArticleId><ArticleId IdType="pubmed">37924708</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosef C.; Knauer M. J.; Nicholson M.; Van Nynatten L. R.; Cepinskas G.; Draghici S.; Han V. K. M.; Fraser D. D. Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. J. Transl. Med. 2023, 21 (1), 377.10.1186/s12967-023-04149-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04149-9</ArticleId><ArticleId IdType="pmc">PMC10257382</ArticleId><ArticleId IdType="pubmed">37301958</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H.; Ashton N. J.; Dobson R. J. B.; Andersson L. M.; Yilmaz A.; Blennow K.; Gisslen M.; Zetterberg H. Proteomic blood profiling in mild, severe and critical COVID-19 patients. Sci. Rep. 2021, 11 (1), 6357.10.1038/s41598-021-85877-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85877-0</ArticleId><ArticleId IdType="pmc">PMC7973581</ArticleId><ArticleId IdType="pubmed">33737684</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C.; Faghy M. A.; Chidley C.; Phillips B. E.; Bewick T.; Ashton R. E. Blood Biomarkers of Long COVID: A Systematic Review. Mol. Diagn. Ther. 2024, 28 (5), 537&#x2013;574. 10.1007/s40291-024-00731-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-024-00731-z</ArticleId><ArticleId IdType="pubmed">39103645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A.; Green J.; Pollard J. Jr.; Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 2014, 30 (4), 523&#x2013;530. 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasile E.; Oka T.; Ericsson M.; Nakamura N.; Krieger M. IntraGolgi distribution of the Conserved Oligomeric Golgi (COG) complex. Exp. Cell Res. 2006, 312 (16), 3132&#x2013;3141. 10.1016/j.yexcr.2006.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2006.06.005</ArticleId><ArticleId IdType="pubmed">16857184</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfi O.; Yakirevitch A.; Wald O.; Wandel O.; Izhar U.; Oiknine-Djian E.; Nevo Y.; Elgavish S.; Dagan E.; Madgar O.; et al. Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract. J. Virol. 2021, 95 (14), e001302110.1128/jvi.00130-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00130-21</ArticleId><ArticleId IdType="pmc">PMC8223920</ArticleId><ArticleId IdType="pubmed">33893170</ArticleId></ArticleIdList></Reference><Reference><Citation>Duijvelaar E.; Gisby J.; Peters J. E.; Bogaard H. J.; Aman J. Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. Nat. Commun. 2024, 15 (1), 744.10.1038/s41467-024-44986-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-44986-w</ArticleId><ArticleId IdType="pmc">PMC10811341</ArticleId><ArticleId IdType="pubmed">38272877</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M. R.; Mehta A.; Schneider A. M.; Kays K. R.; Guess J. R.; Gentili M.; Fenyves B. G.; Charland N. C.; Gonye A. L.; Gushterova I.; et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2021, 2 (5), 100287.10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Biji A.; Khatun O.; Swaraj S.; Narayan R.; Rajmani R. S.; Sardar R.; Satish D.; Mehta S.; Bindhu H.; Jeevan M.; et al. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. EBioMedicine 2021, 70, 103525.10.1016/j.ebiom.2021.103525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103525</ArticleId><ArticleId IdType="pmc">PMC8358265</ArticleId><ArticleId IdType="pubmed">34392148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Carballa A.; Rivero-Calle I.; Pardo-Seco J.; Gomez-Rial J.; Rivero-Velasco C.; Rodriguez-Nunez N.; Barbeito-Casti&#xf1;eiras G.; P&#xe9;rez-Freixo H.; Cebey-L&#xf3;pez M.; Barral-Arca R.; et al. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity. Environ. Res. 2022, 210, 112890.10.1016/j.envres.2022.112890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.112890</ArticleId><ArticleId IdType="pmc">PMC8861187</ArticleId><ArticleId IdType="pubmed">35202626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M.; Corrales F. J.; Fernandez-Irigoyen J.; Santamaria E. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can. Learn From the Human Olfactory Axis. Front. Microbiol. 2020, 11, 2101.10.3389/fmicb.2020.02101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.02101</ArticleId><ArticleId IdType="pmc">PMC7536310</ArticleId><ArticleId IdType="pubmed">33071996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H. C.; Hsueh C. H.; Hsu P. M.; Huang R. H.; Tsai C. Y.; Chung N. H.; Chow Y.; Tan T. SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19. EMBO Mol. Med. 2022, 14 (9), e1590410.15252/emmm.202215904.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202215904</ArticleId><ArticleId IdType="pmc">PMC9353388</ArticleId><ArticleId IdType="pubmed">35894122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yapasert R.; Khaw-On P.; Banjerdpongchai R. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules 2021, 26 (24), 7459.10.3390/molecules26247459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26247459</ArticleId><ArticleId IdType="pmc">PMC8706825</ArticleId><ArticleId IdType="pubmed">34946543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M.; Zhang M.; Yang Z.; Zhou Z.; Huang J.; Zhao B. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection. Front. Cell. Infect. Microbiol. 2023, 13, 1217383.10.3389/fcimb.2023.1217383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1217383</ArticleId><ArticleId IdType="pmc">PMC10288995</ArticleId><ArticleId IdType="pubmed">37360529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly P. T.; Xu S.; Wirawan M.; Luo D.; Roca X. ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition. Proc. Natl. Acad. Sci. U.S.A. 2022, 119 (31), e212145311910.1073/pnas.2121453119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2121453119</ArticleId><ArticleId IdType="pmc">PMC9351355</ArticleId><ArticleId IdType="pubmed">35881805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar L.; Liu G.; Gack M. U. ISG15: its roles in SARS-CoV-2 and other viral infections. Trends Microbiol. 2023, 31 (12), 1262&#x2013;1275. 10.1016/j.tim.2023.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2023.07.006</ArticleId><ArticleId IdType="pmc">PMC10840963</ArticleId><ArticleId IdType="pubmed">37573184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainter W.; Lougaris V.; Wallace J. G.; Badran Y.; Hoyos-Bachiloglu R.; Peters Z.; Wilkie H.; Das M.; Janssen E.; Beano A.; et al. Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor -B kinase alpha (IKK&#x3b1;). Sci. Immunol. 2021, 6 (63), eabf672310.1126/sciimmunol.abf6723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf6723</ArticleId><ArticleId IdType="pmc">PMC8930078</ArticleId><ArticleId IdType="pubmed">34533979</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y.; Mou L.; Long Q.; Deng D.; Hu R.; Cheng J.; Wu J. SARS-CoV-2 ORF3a positively regulates NF-&#x3ba;B activity by enhancing IKK&#x3b2;-NEMO interaction. Virus Res. 2023, 328, 199086.10.1016/j.virusres.2023.199086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2023.199086</ArticleId><ArticleId IdType="pmc">PMC10009424</ArticleId><ArticleId IdType="pubmed">36894068</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama K.; Aguiar R. C.; Gu L.; He C.; Freeman G. J.; Kutok J. L.; Aster J. C.; Shipp M. A. The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity. J. Biol. Chem. 2003, 278 (24), 21930&#x2013;21937. 10.1074/jbc.M301157200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301157200</ArticleId><ArticleId IdType="pubmed">12670957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.; Zhang J.; Bouamar H.; Wang Z.; Sun L. Z.; Zhu X. Fbxo22 promotes cervical cancer progression via targeting p57(Kip2) for ubiquitination and degradation. Cell Death Dis. 2022, 13 (9), 805.10.1038/s41419-022-05248-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05248-z</ArticleId><ArticleId IdType="pmc">PMC9489770</ArticleId><ArticleId IdType="pubmed">36127346</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.; Lear T.; Zhao Y.; Zhao J.; Zou C.; Chen B. B.; Mallampalli R. K. F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7. Cell Death Dis. 2015, 6 (2), e163010.1038/cddis.2014.585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.585</ArticleId><ArticleId IdType="pmc">PMC4669792</ArticleId><ArticleId IdType="pubmed">25654763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F.; Wang C.; Bai X.; Ji J.; Huang X. ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis. Balkan Med. J. 2023, 40 (6), 409&#x2013;414. 10.4274/balkanmedj.galenos.2023.2023-4-66.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/balkanmedj.galenos.2023.2023-4-66</ArticleId><ArticleId IdType="pmc">PMC10613738</ArticleId><ArticleId IdType="pubmed">37519006</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J. J. Regulation of dynein-dynactin-driven vesicular transport. Traffic 2017, 18 (6), 336&#x2013;347. 10.1111/tra.12475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12475</ArticleId><ArticleId IdType="pubmed">28248450</ArticleId></ArticleIdList></Reference><Reference><Citation>Urnavicius L.; Zhang K.; Diamant A. G.; Motz C.; Schlager M. A.; Yu M.; Patel N. A.; Robinson C. V.; Carter A. P. The structure of the dynactin complex and its interaction with dynein. Science 2015, 347 (6229), 1441&#x2013;1446. 10.1126/science.aaa4080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa4080</ArticleId><ArticleId IdType="pmc">PMC4413427</ArticleId><ArticleId IdType="pubmed">25814576</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad K.; Alasmari A. F.; Ali N.; Khan R.; Alghamdi A.; Kumar V. Insights into the SARS-CoV-2-Mediated Alteration in the Stress Granule Protein Regulatory Networks in Humans. Pathogens 2021, 10 (11), 1459.10.3390/pathogens10111459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111459</ArticleId><ArticleId IdType="pmc">PMC8624858</ArticleId><ArticleId IdType="pubmed">34832615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo D. N.; Edwards R. J.; Slavutsky A. L. Spectrins: molecular organizers and targets of neurological disorders. Nat. Rev. Neurosci. 2023, 24 (4), 195&#x2013;212. 10.1038/s41583-022-00674-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-022-00674-6</ArticleId><ArticleId IdType="pmc">PMC10598481</ArticleId><ArticleId IdType="pubmed">36697767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapperstein S. K.; Lupashin V. V.; Schmitt H. D.; Waters M. G. Assembly of the ER to Golgi SNARE complex requires Uso1p. J. Cell Biol. 1996, 132 (5), 755&#x2013;767. 10.1083/jcb.132.5.755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.132.5.755</ArticleId><ArticleId IdType="pmc">PMC2120746</ArticleId><ArticleId IdType="pubmed">8603910</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeck C.; Biedenkopf N.; Rohde C.; Becker S.; Halwe S. Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein. Viruses 2023, 15 (4), 824.10.3390/v15040824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040824</ArticleId><ArticleId IdType="pmc">PMC10145535</ArticleId><ArticleId IdType="pubmed">37112806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lata S.; Mishra R.; Arya R. P.; Arora P.; Lahon A.; Banerjea A. C.; Sood V. Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection. J. Mol. Biol. 2022, 434 (5), 167403.10.1016/j.jmb.2021.167403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167403</ArticleId><ArticleId IdType="pmc">PMC8666384</ArticleId><ArticleId IdType="pubmed">34914966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Ayllon B. D.; de Lucas-Rius A.; Mendoza-Garcia L.; Garcia-Garcia T.; Fernandez-Rodriguez R.; Suarez-Cardenas J. M.; Santos F. M.; Corrales F.; Redondo N.; Pedrucci F.; et al. SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling. Front. Immunol. 2023, 14, 1220306.10.3389/fimmu.2023.1220306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1220306</ArticleId><ArticleId IdType="pmc">PMC10399023</ArticleId><ArticleId IdType="pubmed">37545510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah T. R.; Johansen M. D.; Balka K. R.; Ambrose R. L.; Gearing L. J.; Roest J.; Vivian J. P.; Sapkota S.; Jayasekara W. S. N.; Wenholz D. S.; et al. Pharmacological inhibition of TBK1/IKK&#x3b5; blunts immunopathology in a murine model of SARS-CoV-2 infection. Nat. Commun. 2023, 14 (1), 5666.10.1038/s41467-023-41381-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41381-9</ArticleId><ArticleId IdType="pmc">PMC10507085</ArticleId><ArticleId IdType="pubmed">37723181</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami N.; Aghbash P. S.; Shamekh A.; Entezari-Maleki T.; Nahand J. S.; Sales A. J.; Baghi H. B. SARS-CoV-2: Receptor and Co-receptor Tropism Probability. Curr. Microbiol. 2022, 79 (5), 133.10.1007/s00284-022-02807-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-02807-7</ArticleId><ArticleId IdType="pmc">PMC8923825</ArticleId><ArticleId IdType="pubmed">35292865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.; Song Z.; Qi Y.; Feng X.; Xu N.; Sun Y.; Wu X.; Yao X.; Mao Q.; Li X.; et al. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 2012, 287 (9), 6406&#x2013;6420. 10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S.; Ohka S.; Fujii K.; Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 2013, 87 (6), 3335&#x2013;3347. 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Heybrock S.; Kanerva K.; Meng Y.; Ing C.; Liang A.; Xiong Z. J.; Weng X.; Ah Kim Y.; Collins R.; Trimble W.; et al. Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export. Nat. Commun. 2019, 10 (1), 3521.10.1038/s41467-019-11425-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11425-0</ArticleId><ArticleId IdType="pmc">PMC6684646</ArticleId><ArticleId IdType="pubmed">31387993</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernathy E.; Glaunsinger B. Emerging roles for RNA degradation in viral replication and antiviral defense. Virology 2015, 479&#x2013;480, 600&#x2013;608. 10.1016/j.virol.2015.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.007</ArticleId><ArticleId IdType="pmc">PMC4424162</ArticleId><ArticleId IdType="pubmed">25721579</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A. K.; Blanco M. R.; Bruce E. A.; Honson D. D.; Chen L. M.; Chow A.; Bhat P.; Ollikainen N.; Quinodoz S. A.; Loney C.; et al. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. Cell. 2020, 183 (5), 1325&#x2013;1339.e21. 10.1016/j.cell.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergant V.; Schnepf D.; de Andrade Kratzig N.; Hubel P.; Urban C.; Engleitner T.; Dijkman R.; Ryffel B.; Steiger K.; Knolle P. A.; et al. mRNA 3&#x2032;UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus. Nat. Commun. 2023, 14 (1), 4906.10.1038/s41467-023-40469-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40469-6</ArticleId><ArticleId IdType="pmc">PMC10427651</ArticleId><ArticleId IdType="pubmed">37582777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C. The SF3b complex: splicing and beyond. Cell. Mol. Life Sci. 2020, 77 (18), 3583&#x2013;3595. 10.1007/s00018-020-03493-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03493-z</ArticleId><ArticleId IdType="pmc">PMC7452928</ArticleId><ArticleId IdType="pubmed">32140746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.; Yu F.; Xu N.; Lu L. Grass carp reovirus capsid protein interacts with cellular proteasome subunit beta-type 7: Evidence for the involvement of host proteasome during aquareovirus infection. Fish Shellfish Immunol. 2020, 98, 77&#x2013;86. 10.1016/j.fsi.2019.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2019.12.047</ArticleId><ArticleId IdType="pubmed">31846778</ArticleId></ArticleIdList></Reference><Reference><Citation>Plume J.; Galvanovskis A.; Smite S.; Romanchikova N.; Zayakin P.; Line A. Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients. J. Transl. Med. 2022, 20 (1), 176.10.1186/s12967-022-03382-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03382-y</ArticleId><ArticleId IdType="pmc">PMC9012069</ArticleId><ArticleId IdType="pubmed">35428263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafkamp F. M. J.; Taanman-Kueter E. W. M.; van Capel T. M. M.; Wynberg E.; van Willigen H. D. G.; Verveen A.; Kootstra N. A.; Nieuwkerk P.; de Jong M. D.; de Bree G. J.; et al. Aberrant neutrophil degranulation in hospitalized patients with COVID-19 partially remains for 6 months. Eur. J. Immunol. 2023, 54, e235040410.1002/eji.202350404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202350404</ArticleId><ArticleId IdType="pubmed">37853954</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M. C.; Bonham K. S.; Anam F. A.; Walker T. A.; Faliti C. E.; Ishii Y.; Kaminski C. Y.; Ruunstrom M. C.; Cooper K. R.; Truong A. D.; et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat. Commun. 2023, 14 (1), 4201.10.1038/s41467-023-40012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzmann M.; Gibler P.; Haider P.; Brekalo M.; Plasenzotti R.; Filip T.; Nistelberger R.; Hartmann B.; Wojta J.; Hengstenberg C.; et al. Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model. J. Thromb. Haemostasis 2024, 22 (1), 188&#x2013;198. 10.1016/j.jtha.2023.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.09.014</ArticleId><ArticleId IdType="pubmed">37748582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y.; Ye L.; Cai H.; Zhu G.; Wang J.; Zhu M.; Song X.; Yang C.; Jin M. SERPINB10 contributes to asthma by inhibiting the apoptosis of allergenic Th2 cells. Respir Res. 2021, 22 (1), 178.10.1186/s12931-021-01757-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01757-1</ArticleId><ArticleId IdType="pmc">PMC8201873</ArticleId><ArticleId IdType="pubmed">34126986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann A.; Lafferton B.; Plotz G.; Zeuzem S.; Brieger A. Expression and secretion of the pro-inflammatory cytokine IL-8 is increased in colorectal cancer cells following the knockdown of non-erythroid spectrin alphaII. Int. J. Oncol. 2020, 56 (6), 1551&#x2013;1564. 10.3892/ijo.2020.5026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2020.5026</ArticleId><ArticleId IdType="pubmed">32236629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollinedo F.; Perez-Sala D.; Gajate C.; Jimenez B.; Rodriguez P.; Lacal J. C. Localization of rap1 and rap2 proteins in the gelatinase-containing granules of human neutrophils. FEBS Lett. 1993, 326 (1&#x2013;3), 209&#x2013;214. 10.1016/0014-5793(93)81792-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(93)81792-X</ArticleId><ArticleId IdType="pubmed">8391995</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W.; Qi Y.; Cui X.; Huo Q.; Zhu L.; Zhang A.; Tan M.; Hong Q.; Yang Y.; Zhang H.; et al. Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues. Biomed Res. Int. 2018, 2018, 1&#x2013;7. 10.1155/2018/6242173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6242173</ArticleId><ArticleId IdType="pmc">PMC6029443</ArticleId><ArticleId IdType="pubmed">30018982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.; Richards A.; Barrasa M. I.; Hughes S. H.; Young R. A.; Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc. Natl. Acad. Sci. U.S.A. 2021, 118 (21), e210596811810.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccosanti F.; Di Rienzo M.; Romagnoli A.; Colavita F.; Refolo G.; Castilletti C.; Agrati C.; Brai A.; Manetti F.; Botta L.; et al. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res. 2021, 190, 105064.10.1016/j.antiviral.2021.105064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2021.105064</ArticleId><ArticleId IdType="pmc">PMC7997689</ArticleId><ArticleId IdType="pubmed">33781803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y.; Rehawi G.; Moyon L.; Gerstner N.; Ogris C.; Knauer-Arloth J.; Bittner F.; Marsico A.; Mueller N. S. Network Embedding Across Multiple Tissues and Data Modalities Elucidates the Context of Host Factors Important for COVID-19 Infection. Front. Genet. 2022, 13, 909714.10.3389/fgene.2022.909714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.909714</ArticleId><ArticleId IdType="pmc">PMC9315940</ArticleId><ArticleId IdType="pubmed">35903362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou W.; Wang S.; Wu H.; Xue L.; Wang B.; Wang S.; Wang H. Small GTPase-A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery. Viruses 2022, 14 (9), 2044.10.3390/v14092044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092044</ArticleId><ArticleId IdType="pmc">PMC9504349</ArticleId><ArticleId IdType="pubmed">36146850</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincenzi M.; Mercurio F. A.; Leone M. EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections. Curr. Med. Chem. 2023, 31, 5670.10.2174/0109298673256638231003111234.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0109298673256638231003111234</ArticleId><ArticleId IdType="pubmed">37828671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobley J. A.; Molyvdas A.; Kojima K.; Jilling T.; Li J. L.; Garantziotis S.; et al. The SARS-CoV-2 Spike S1 Protein Induces Global Proteomic Changes in ATII-Like Rat L2 Cells that are Attenuated by Hyaluronan. bioRxiv 2022, L413.10.1152/ajplung.00282.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00282.2022</ArticleId><ArticleId IdType="pmc">PMC10042596</ArticleId><ArticleId IdType="pubmed">36719087</ArticleId></ArticleIdList></Reference><Reference><Citation>Fackler O. T.; Luo W.; Geyer M.; Alberts A. S.; Peterlin B. M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 1999, 3 (6), 729&#x2013;739. 10.1016/S1097-2765(01)80005-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)80005-8</ArticleId><ArticleId IdType="pubmed">10394361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos S. N.; Spengler B. A.; Kisselbach K.; Evans A. E.; Biedler J. L.; Ross R. A. The human non-muscle &#x3b1;-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 2000, 19 (3), 380&#x2013;386. 10.1038/sj.onc.1203310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1203310</ArticleId><ArticleId IdType="pubmed">10656685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>